1
|
Noguchi T, Hirao M, Okamura G, Etani Y, Ebina K, Tsuboi H, Goshima A, Miyama A, Takahi K, Takami K, Tsuji S, Okada S, Hashimoto J. Stabilizing effect of total ankle arthroplasty by distal translation and lateralization of talus in varus ankle deformity. Musculoskelet Surg 2024:10.1007/s12306-024-00820-6. [PMID: 38705948 DOI: 10.1007/s12306-024-00820-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Accepted: 03/23/2024] [Indexed: 05/07/2024]
Abstract
BACKGROUND In end-stage arthritis indicated for total ankle arthroplasty (TAA), full-thickness cartilage damage, subchondral bone defect/shaving, and fluttering of the talar dome occur, shortening the distance between the tibial and talar insertions of ligaments and leading to laxity of ligaments surrounding the ankle joint. Under such conditions, medial ligaments (including the deltoid ligament) would not be expected to function properly. To stabilize the ankle joint during the stance phase, medial ligament function under tension is important. This study therefore examined whether TAA contributes to lengthening of the medial tibio-talar joint as evaluated radiographically, as a preferable method for achieving tensile effects on medial ligaments. MATERIALS AND METHODS Twenty-four feet with end-stage varus deformity of the ankle joint that underwent TAA were retrospectively investigated, excluding cases with any malleolar osteotomy or fracture. Distance between proximal and distal insertions of medial ligaments, lateralization of the talus, and talar tilt angle under valgus/varus stress condition were evaluated pre- and postoperatively. RESULTS Distance between proximal and distal insertions of medial ligaments was significantly elongated after TAA. At the same time, the talus showed significant lateralization. Furthermore, talar tilt under valgus/varus stress conditions was also significantly reduced after TAA. CONCLUSION TAA affects distal translation and lateralization of the talus in cases of varus ankle deformity. These effects might contribute to re-providing tensile force on lax medial ligaments, improving ligament function.
Collapse
Affiliation(s)
- T Noguchi
- Department of Orthopaedic Surgery, Osaka Minami Medical Center, National Hospital Organization, 2-1 Kidohigashi, Kawachinagano, Osaka, 586-8521, Japan
| | - M Hirao
- Department of Orthopaedic Surgery, Osaka Minami Medical Center, National Hospital Organization, 2-1 Kidohigashi, Kawachinagano, Osaka, 586-8521, Japan.
| | - G Okamura
- Department of Orthopaedic Surgery, Osaka Minami Medical Center, National Hospital Organization, 2-1 Kidohigashi, Kawachinagano, Osaka, 586-8521, Japan
| | - Y Etani
- Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
| | - K Ebina
- Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
| | - H Tsuboi
- Department of Orthopaedic Surgery, Osaka Rosai Hospital, Osaka, Japan
| | - A Goshima
- Department of Orthopaedic Surgery, Osaka Rosai Hospital, Osaka, Japan
| | - A Miyama
- Department of Orthopaedic Surgery, Osaka-Toneyama Medical Center, National Hospital Organization, Osaka, Japan
| | - K Takahi
- Department of Orthopaedic Surgery, Osaka-Toneyama Medical Center, National Hospital Organization, Osaka, Japan
| | - K Takami
- Department of Orthopaedic Surgery, Nippon Life Hospital, Osaka, Japan
| | - S Tsuji
- Department of Orthopaedic Surgery, Nippon Life Hospital, Osaka, Japan
| | - S Okada
- Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
| | - J Hashimoto
- Department of Orthopaedic Surgery, Osaka Minami Medical Center, National Hospital Organization, 2-1 Kidohigashi, Kawachinagano, Osaka, 586-8521, Japan
| |
Collapse
|
2
|
Hashimoto J, Fujita E, Tanimoto K, Kondo S, Matsumoto-Miyai K. Effects of Cardiac Glycoside Digoxin on Dendritic Spines and Motor Learning Performance in Mice. Neuroscience 2024; 541:77-90. [PMID: 38278474 DOI: 10.1016/j.neuroscience.2024.01.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2023] [Revised: 01/17/2024] [Accepted: 01/22/2024] [Indexed: 01/28/2024]
Abstract
Synapse formation following the generation of postsynaptic dendritic spines is essential for motor learning and functional recovery after brain injury. The C-terminal fragment of agrin cleaved by neurotrypsin induces dendritic spine formation in the adult hippocampus. Since the α3 subunit of sodium-potassium ATPase (Na/K ATPase) is a neuronal receptor for agrin in the central nervous system, cardiac glycosides might facilitate dendritic spine formation and subsequent improvements in learning. This study investigated the effects of cardiac glycoside digoxin on dendritic spine turnover and learning performance in mice. Golgi-Cox staining revealed that intraperitoneal injection of digoxin less than its IC50 in the brain significantly increased the density of long spines (≥2 µm) in the cerebral cortex in wild-type mice and neurotrypsin-knockout (NT-KO) mice showing impairment of activity-dependent spine formation. Although the motor learning performance of NT-KO mice was significantly lower than control wild-type mice under the control condition, low doses of digoxin enhanced performance to a similar degree in both strains. In NT-KO mice, lower digoxin doses equivalent to clinical doses also significantly improved motor learning performance. These data suggest that lower doses of digoxin could modify dendritic spine formation or recycling and facilitate motor learning in compensation for the disruption of neurotrypsin-agrin pathway.
Collapse
Affiliation(s)
- Junichi Hashimoto
- Graduate School of Rehabilitation Science, Osaka Metropolitan University, 3-7-30 Habikino, Habikino-City, Osaka 583-8555, Japan
| | - Erika Fujita
- Graduate School of Rehabilitation Science, Osaka Metropolitan University, 3-7-30 Habikino, Habikino-City, Osaka 583-8555, Japan
| | - Keisuke Tanimoto
- Graduate School of Rehabilitation Science, Osaka Metropolitan University, 3-7-30 Habikino, Habikino-City, Osaka 583-8555, Japan
| | - Suzuo Kondo
- Graduate School of Rehabilitation Science, Osaka Metropolitan University, 3-7-30 Habikino, Habikino-City, Osaka 583-8555, Japan
| | - Kazumasa Matsumoto-Miyai
- Graduate School of Rehabilitation Science, Osaka Metropolitan University, 3-7-30 Habikino, Habikino-City, Osaka 583-8555, Japan.
| |
Collapse
|
3
|
Ichikawa T, Ono S, Nagafuji Y, Kobayashi M, Yashiro H, Koizumi J, Uchiyama F, Fujii Y, Hasebe T, Terayama H, Hashimoto J. Congenital venous anomalies associated with retrocaval ureter: evaluation using computed tomography. Folia Morphol (Warsz) 2022; 82:300-306. [PMID: 35411547 DOI: 10.5603/fm.a2022.0036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Revised: 03/05/2022] [Accepted: 03/07/2022] [Indexed: 11/25/2022]
Abstract
BACKGROUND Retrocaval ureter is a rare congenital anomaly resulting from anomalous development of inferior vena cava (IVC) and not from anomalous of the ureter. The anomaly always occurs on the right side due to regression of right supracardinal vein and persistence of right posterior cardinal vein. Retrocaval ureter tends to be associated with various vena cava anomalies because of the embryogenesis. We aimed to identify the prevalence of associated congenital venous anomalies (CVA) resulting from cardinal vein development in adults with retrocaval ureter using computed tomography (CT) images. MATERIALS AND METHODS The study included 22 adults with retrocaval ureter. We evaluated CT findings and determined the incidence of associated CVA using thin slice data sets from CT scanner with 64 or more detectors. We compared the prevalence of CVA in the retrocaval ureter group (mean age: 57±19 years) and in the control group of 6189 adults with normal ureter (mean age: 66±14 years). RESULTS In the retrocaval ureter group, 4 adults (18.2 %) had CVA including double IVC, right double IVC, preisthmic IVC with horseshoe kidney, and preaortic iliac confluence. One of 2 adults with preaortic iliac confluence had right double right IVC. In the control group, 49 adults (0.79%) had CVA including 37 double IVCe, 11 left IVCe, and 1 IVC interruption azygos continuation. Fifteen horseshow kidneys were found. The prevalence of associated CVA in the retrocaval ureter group was higher than that in the control group (p<0.001). CONCLUSIONS Retrocaval ureter is frequently associated with CVA. Various CVA with retrocaval ureter could happen because of abnormal development of not only the right posterior or supra cardinal vein but also other cardinal veins.
Collapse
Affiliation(s)
- T Ichikawa
- Department of Radiology, Tokai University School of Medicine, Isehara-si, Japan.
| | - S Ono
- Department of Radiology, Tokai University School of Medicine, Isehara-si, Japan
| | - Y Nagafuji
- Department of Radiology, Ebina General Hospital, Ebina, Japan
| | - M Kobayashi
- Department of Radiology, Hirastuka City Hospital, Kanagawa, Japan
| | - H Yashiro
- Department of Radiology, Hirastuka City Hospital, Kanagawa, Japan
| | - J Koizumi
- Department of Radiology, Chiba University, 1-8-1 Inohana, Chuo-Ku, 260-8677 Chiba, Japan
| | - F Uchiyama
- Department of Radiology, Ebina General Hospital, Ebina, Japan
| | - Y Fujii
- Department of Radiology, Fujisawa City Hospital, Kanagawa, Japan
| | - T Hasebe
- Department of Radiology, Tokai University Hachioji Hospital, Tokyo, Japan
| | - H Terayama
- Department of Anatomy, Tokai University School of Medicine, Kanagawa, Japan
| | - J Hashimoto
- Department of Radiology, Tokai University School of Medicine, Isehara-si, Japan
| |
Collapse
|
4
|
Okuyama E, Kawatani M, Hashimoto J, Tanimoto K, Hashimoto M, Matsumoto‐Miyai K. The nitric oxide-cyclic guanosine monophosphate pathway inhibits the bladder ATP release in response to a physiological or pathological stimulus. Physiol Rep 2021; 9:e14938. [PMID: 34288526 PMCID: PMC8290832 DOI: 10.14814/phy2.14938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2021] [Revised: 05/18/2021] [Accepted: 05/29/2021] [Indexed: 11/24/2022] Open
Abstract
The release of ATP from the epithelium of the urinary bladder (urothelium) in response to mechanical/chemical stimuli contributes to the visceral sensation in the micturition reflex. The nitric oxide (NO)-mediated induction of cyclic guanosine monophosphate (cGMP) has been detected in urothelial cells and may inhibit the micturition reflex. However, the function of the NO-cGMP pathway in the regulation of urothelial ATP release remains poorly understood in contrast to its effects on smooth muscles or primary afferent nerves. Therefore, we investigated the relevance of the NO-cGMP pathway to ATP release on the mucosal side in the present study. The administration of l-arginine (NO precursor) or NOC 12 (NO donor) significantly reduced ATP release to the mucosal side at a physiologically normal urine storage pressure (5 cmH2 O). L-NAME (NO synthase inhibitor) significantly increased the distention-induced release of ATP. The phosphodiesterase-5 inhibitor, sildenafil, which increases cGMP levels, inhibited distention-induced ATP release. Furthermore, sildenafil significantly reduced ATP release in response to the administration of lipopolysaccharide. These results suggest that the NO-cGMP pathway inhibited urothelial ATP release during the storage phase under both physiological and pathological conditions.
Collapse
Affiliation(s)
- Eriko Okuyama
- Department of RadiologyAkita University Graduate School of MedicineAkitaJapan
| | - Masahito Kawatani
- Department of NeurophysiologyAkita University Graduate School of MedicineAkitaJapan
| | - Junichi Hashimoto
- Graduate School of Comprehensive RehabilitationOsaka Prefecture UniversityHabikinoOsakaJapan
| | - Keisuke Tanimoto
- Graduate School of Comprehensive RehabilitationOsaka Prefecture UniversityHabikinoOsakaJapan
| | - Manabu Hashimoto
- Department of RadiologyAkita University Graduate School of MedicineAkitaJapan
| | | |
Collapse
|
5
|
Tsuji S, Tomita T, Higashiyama M, Noguchi T, Mouri T, Hashimoto J. AB0840 INFLUENCE OF PSORIATIC ARTHRITIS (PsA) ON BONE LOSS AND ANALYSIS BETWEEN AXIAL AND PERIPHERAL PsA IN JAPANESE PATIENTS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.2826] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Osteoporosis is one of the major comorbidities in patients with psoriasis and psoriatic arthritis (PsA). It has been reported that PsA induces fragility bone structure1and high risk of osteoporosis2. However, there is no report about relationship between psoriatic arthritis and osteoporosis in Japanese patients and its mechanism has not been elucidated.Objectives:The objective of this study is to investigate influence of PsA on bone mineral density (BMD) and its mechanism including analysis between axial and peripheral PsA in Japanese patients.Methods:This study was retrospective study. We examined 58 cases of PsA and 29 cases of RA that underwent DXA tests at our facility from January 2017 to July 2019 (Table 1). The axial PsA was classified as axial SpA using the ASAS classification criteria. First, we investigated influence of PsA containing both axial (n=30,19 males, 11 females, mean age: 50.6 years) and peripheral (n=28, 19 males, 9 females, mean age: 58.0 years) subtypes on BMD measured by dual-energy X-ray absorptiometry. Second, we measured serum bone metabolism markers (P1NP: type I procollagen-N-propeptide, TRACP-5b: tartrate-resistant acid phosphatase 5b) and bone remodeling effector molecules (Dkk1: Dickkopf1, sclerostin, 25(OH)D: 25-hydroxyvitamin D) to elucidate differences in BMD between axial and peripheral PsA. Furthermore, rheumatoid arthritis (RA) (n=29, 2 males, 27 females, mean age: 66.2 years), as a reference disease, was also evaluated for comparison with axial and peripheral PsA.Osteoporosis and Osteopenia were defined as T-score ≤ -2.5 or %YAM ≤70%., -1.0< T-score >-2.5 or 80>%YAM >70% respectively.Results:58 patients with PsA indicated low T-score, Z-score and %YAM in both lumbar spine and proximal femur (Table 1). Axial PsA and peripheral PsA showed osteoporosis in 16.7% and 35.7%, and osteopenia in 20.0% and 32.1%, respectively, despite the fact that there were many middle-aged men. Comparison between axial and peripheral PsA, axial PsA showed higher BMDthan peripheral PsA. In bone remodeling makers, P1NP in both PsA were almost same, but TRACP-5b, bone resorption marker, in axial PsA was lower than that in peripheral PsA(Table 2). In bone remodeling influencer molecules, Dkk1, and sclerostin in axial PsA was slightly higher than those in peripheral PsA, whereas 25(OH)D is almost same as the both PsA. On the other hand, RA also indicated low T-score and %YAM in both lumbar spine. P1NP in RA showed slightly lower, but TRACP-5b and Homocysteine in RA higher than those in axial and peripheral PsA. Dkk1 and sclerostin in RA were slightly lower than those in both PsA.Conclusion:Peripheral PsA indicated more severe bone loss than axial PsA in our study. There were some differences in bone remodeling markers and bone remodeling effector molecules between axial and peripheral PsA, but the relationships between BMD and these parameters were not confirmed. Further studies are needed to elucidate bone loss mechanism in these PsA.References:[1]Zhu TY, et al. Osteoporosis Int. 2015; 26:261–272.[2]Kathuria R, et al. J Am Acad Dermatol. 2017;76:1045-53.Disclosure of Interests:Shigeyoshi Tsuji Grant/research support from: Eli Lilly, Speakers bureau: AbbVie, Asahi Kasei, Chugai, Daiichi Sankyo, Eli Lilly, Eisai, Mitsubishi Tanabe, Celgene, and Novartis Pharma K.K., Tetsuya Tomita Consultant of: Eli Lilly and Company, Mari Higashiyama: None declared, Takaaki Noguchi: None declared, Toshikazu Mouri: None declared, Jun Hashimoto Speakers bureau: AbbVie, Asahi Kasei, Chugai, Daiichi Sankyo, Eli Lilly, Eisai, Mitsubishi Tanabe, Celgene, and Novartis Pharma K.K.
Collapse
|
6
|
Sumiya S, Kawabata S, Ushio S, Sasaki T, Hashimoto J, Hoshino Y, Sekihara K, Watanabe T, Adachi Y, Okawa A. Visualization of electrophysiological activity in the cervical spinal cord using magnetospinography. J Neurol Sci 2019. [DOI: 10.1016/j.jns.2019.10.1494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
7
|
Sumiya S, Kawabata S, Ushio S, Sasaki T, Hashimoto J, Yoshii T, Okawa A. Cervical spinal cord injury associated with neck flexion in posterior cervical decompression -Verification by intraoperative spinal cord monitoring. J Neurol Sci 2019. [DOI: 10.1016/j.jns.2019.10.911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
8
|
Ebina K, Hirao M, Hashimoto J, Matsuoka H, Iwahashi T, Chijimatsu R, Etani Y, Okamura G, Miyama A, Yoshikawa H. Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis. Osteoporos Int 2018; 29:1627-1636. [PMID: 29574517 DOI: 10.1007/s00198-018-4492-y] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/23/2017] [Accepted: 03/16/2018] [Indexed: 11/25/2022]
Abstract
UNLABELLED In biologic-naïve female RA patients, switching oral BPs to DMAb significantly reduced radiographic joint destruction compared to continuing oral BPs or switching to TPTD at 12 months, which were significantly associated with a decrease of a bone resorption marker at 6 months. INTRODUCTION The aim of this study was to clarify the effects of switching oral bisphosphonates (BPs) to denosumab (DMAb) or daily teriparatide (TPTD) on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis (RA). METHODS A retrospective, case-controlled study involving 90 female RA patients (mean age 68.2 years, 96.7% postmenopausal, disease activity score assessing 28 joints with CRP (DAS28-CRP) 2.4, methotrexate treatment 81.1%, prednisolone treatment 68.9%, and prior BP treatment 44.8 months), who were allocated depending on each patient's and physician's wishes, to (1) the BP-continue group (n = 30), (2) the switch-to-DMAb group (n = 30), or (3) the switch-to-TPTD group (n = 30), was conducted. Patients were retrospectively selected to minimize the difference of possible clinical backgrounds that may affect the joint destruction of RA. The primary endpoint was to clarify the change of the modified total Sharp score (mTSS) from baseline to 12 months. RESULTS After 12 months, the mean changes of the modified Sharp erosion score were significantly lower in the switch-to-DMAb group (0.2 ± 0.1; mean ± standard error) than in the switch-to-TPTD group (1.3 ± 0.5; P < 0.05), and mTSS was significantly lower in the switch-to-DMAb group (0.3 ± 0.2) than in the BP-continue group (1.0 ± 0.3; P < 0.05) and the switch-to-TPTD group (1.7 ± 0.6; P < 0.05). The logistic regression analysis showed that mTSS changes were significantly associated with the percent changes of TRACP-5b at 6 months (β = 0.30, 95% CI = 0.002-0.016; P < 0.01). CONCLUSIONS Changes of systemic bone turnover induced by switching BPs to DMAb or TPTD may affect not only systemic bone mass, but also local joint destruction, and its clinical relevance should be considered comprehensively.
Collapse
Affiliation(s)
- K Ebina
- Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
| | - M Hirao
- Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
| | - J Hashimoto
- Department of Rheumatology, National Hospital Organization, Osaka Minami Medical Center, 2-1 Kidohigashi, Kawachinagano, Osaka, 586-8521, Japan
| | - H Matsuoka
- Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
| | - T Iwahashi
- Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
| | - R Chijimatsu
- Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
| | - Y Etani
- Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
| | - G Okamura
- Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
| | - A Miyama
- Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
| | - H Yoshikawa
- Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
| |
Collapse
|
9
|
Kida K, Sumitani M, Ogata T, Kotake R, Natori A, Hashimoto J, Shimokawa T, Yamauchi H, Yamauchi T. Abstract P6-12-26: The axonal damage marker, serum phosphorylated neurofilament heavy subunit, as a potential marker of chemotherapy-induced neuropathy. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p6-12-26] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Chemotherapy-induced neurologic disorders such as peripheral neuropathy and cognitive disturbance are clinically significant problems for cancer survivors, but their objective assessment methods have not been established. We previously reported in a cross-sectional study that the serum phosphorylated neurofilament heavy subunit (pNF-H), a biomarker of axonal damage, was increased in breast cancer patients treated with chemotherapy. The aim of this study is to temporally assess the neurological adverse events and evaluate the association of serum pNF-H level with cognitive functions and neuropathy following sequential chemotherapy.
Methods: Thirty-five breast cancer patients who received neoadjuvant or adjuvant chemotherapy were enrolled prospectively. They underwent brain MRI and cognitive function tests including Controlled Oral Word Association (COWA), Trail Making Test (TMT), and Hopkins Verbal Learning Test-Revised (HVLT-R) before chemotherapy (baseline), one month after completing sequential chemotherapy (post-phase) and more than six months after completing chemotherapy (late-phase). Serum pNF-H levels and questionnaires reporting peripheral neuropathy were measured at the three phases, and every 3 weeks during chemotherapy. Brain MRI volumetry was calculated by the automatic analysis software, BAAD® (Brain Anatomical Analysis using Dartel). The correlations among cognitive functions, brain volume, peripheral neuropathy and serum pNF-H levels were statistically analyzed.
Results: Patients' median age was 48 years (range 24-71). A decrease of more than 10% in cognitive function test (COWA) scores was seen in 10 cases (31%) at post-phase. A brain volume loss of more than 10% was seen in 5 cases (15%) at post-phase. The correlation between brain volume change and cognitive disturbance was not significant (p=0.45) and both changes were improved at late-phase. A peripheral neuropathy grade above CTCAE grade 2 was seen in 19 cases (54%). The neuropathy was significantly more severe in anthracycline followed by taxane regimen than taxane followed by anthracycline during chemotherapy (p=0.016), although this difference was not seen at the late-phase (p=0.08). An elevated serum pNF-H level at baseline was seen in only one case, and this case demonstrated the cognitive disturbance, brain volume loss, and peripheral neuropathy following chemotherapy. During chemotherapy, pNF-H was elevated in 24 patients (69%), with especially higher levels noted during the taxane regimen compared to the anthracycline regimen (p=0.019). In the cases treated with anthracycline followed by taxane, the taxane-phase elevation was especially significant (p=0.014). The maximum pNF-H level during taxane therapy was significantly correlated with peripheral neuropathy grade (p=0.002). At late-phase, the significant reduction of pNF-H level was seen in all cases.
Conclusions: Change of cognitive function, brain volume and peripheral neuropathy was observed following chemotherapy in breast cancer patients. This study suggests that the serum axonal damage marker, pNF-H, may reflect chemotherapy-induced neuropathy.
Citation Format: Kida K, Sumitani M, Ogata T, Kotake R, Natori A, Hashimoto J, Shimokawa T, Yamauchi H, Yamauchi T. The axonal damage marker, serum phosphorylated neurofilament heavy subunit, as a potential marker of chemotherapy-induced neuropathy [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P6-12-26.
Collapse
Affiliation(s)
- K Kida
- St.Luke's International Hospital, Tokyo, Japan; University of Tokyo, Tokyo, Japan; National Rehabilitation Center for Persons with Disabilities, Saitama, Japan; Princess Margaret Cancer Centre, Tronto, Canada; Wakayama Medical University, Wakayama, Japan
| | - M Sumitani
- St.Luke's International Hospital, Tokyo, Japan; University of Tokyo, Tokyo, Japan; National Rehabilitation Center for Persons with Disabilities, Saitama, Japan; Princess Margaret Cancer Centre, Tronto, Canada; Wakayama Medical University, Wakayama, Japan
| | - T Ogata
- St.Luke's International Hospital, Tokyo, Japan; University of Tokyo, Tokyo, Japan; National Rehabilitation Center for Persons with Disabilities, Saitama, Japan; Princess Margaret Cancer Centre, Tronto, Canada; Wakayama Medical University, Wakayama, Japan
| | - R Kotake
- St.Luke's International Hospital, Tokyo, Japan; University of Tokyo, Tokyo, Japan; National Rehabilitation Center for Persons with Disabilities, Saitama, Japan; Princess Margaret Cancer Centre, Tronto, Canada; Wakayama Medical University, Wakayama, Japan
| | - A Natori
- St.Luke's International Hospital, Tokyo, Japan; University of Tokyo, Tokyo, Japan; National Rehabilitation Center for Persons with Disabilities, Saitama, Japan; Princess Margaret Cancer Centre, Tronto, Canada; Wakayama Medical University, Wakayama, Japan
| | - J Hashimoto
- St.Luke's International Hospital, Tokyo, Japan; University of Tokyo, Tokyo, Japan; National Rehabilitation Center for Persons with Disabilities, Saitama, Japan; Princess Margaret Cancer Centre, Tronto, Canada; Wakayama Medical University, Wakayama, Japan
| | - T Shimokawa
- St.Luke's International Hospital, Tokyo, Japan; University of Tokyo, Tokyo, Japan; National Rehabilitation Center for Persons with Disabilities, Saitama, Japan; Princess Margaret Cancer Centre, Tronto, Canada; Wakayama Medical University, Wakayama, Japan
| | - H Yamauchi
- St.Luke's International Hospital, Tokyo, Japan; University of Tokyo, Tokyo, Japan; National Rehabilitation Center for Persons with Disabilities, Saitama, Japan; Princess Margaret Cancer Centre, Tronto, Canada; Wakayama Medical University, Wakayama, Japan
| | - T Yamauchi
- St.Luke's International Hospital, Tokyo, Japan; University of Tokyo, Tokyo, Japan; National Rehabilitation Center for Persons with Disabilities, Saitama, Japan; Princess Margaret Cancer Centre, Tronto, Canada; Wakayama Medical University, Wakayama, Japan
| |
Collapse
|
10
|
Yazaki S, Hashimoto J, Ogita S, Nakano E, Yamauchi T. Lower response to T-DM1 in metastatic breast cancer patients with HER2 IHC score of 2 and FISH positive compared with IHC score of 3. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx365.071] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
11
|
Shimomura A, Yonemori K, Masuda N, Aogi K, Takahashi M, Naito Y, Shimizu S, Nakamura R, Hamada A, Michimae H, Hashimoto J, Yamamoto H, Shimizu C, Tamura K, Fujiwara Y. Gene alteration in triple negative breast cancer patients in a phase I/II study of combination therapy with eribulin and olaparib. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx365.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
12
|
Lee S, Hashimoto J, Suzuki T, Satoh A. The effects of exercise load during development on oxidative stress levels and antioxidant potential in adulthood. Free Radic Res 2017; 51:179-186. [PMID: 28166650 DOI: 10.1080/10715762.2017.1291939] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
The objective of this study was to elucidate the impact of physical activity during the growth period as well as on oxidative stress and antioxidative potential in adulthood. The experimental animals used were four-week old male Wistar rats, which were randomly divided into three groups. The exercise loads were as follows: control (CON), treadmill exercise (TE), and jumping exercise (JE). The exercise was performed at the same time of day, at a frequency of five days per week, for eight weeks. Derivatives of reactive oxygen metabolites (d-ROSs) and biological antioxidant potential (BAP) were measured during periods of rest prior to commencement of the experiment and after the experiment. Analysis was conducted using a Wilcoxon signed-rank test and Schaffer's multiple comparison procedure and the significance level was set at p < 0.05. The percent increase in d-ROM levels in the JE group, which experienced short-duration intense exercise loads, was higher than that in the TE group, which experienced moderately intense exercise loads. However, BAP, which is an index of antioxidant potential, markedly decreased in adulthood in the CON group, as compared to that in the developmental period, whereas the exercise groups showed no notable changes in BAP levels. Oxidative stress levels and antioxidant potential are affected differently in adulthood, depending on the intensity of sustained exercise loads experienced during development. Results suggested that in order to increase antioxidant potential, while taking oxidative stress production into account, moderately intense exercise loads are more desirable than highly intense exercise loads.
Collapse
Affiliation(s)
- S Lee
- a Department of Physical Therapy , Aomori University of Health and Welfare , Aomori-shi , Japan
| | - J Hashimoto
- a Department of Physical Therapy , Aomori University of Health and Welfare , Aomori-shi , Japan
| | - T Suzuki
- a Department of Physical Therapy , Aomori University of Health and Welfare , Aomori-shi , Japan
| | - A Satoh
- b Department of Nursing , Hirosaki University of Health and Welfare , Hirosaki-shi , Japan
| |
Collapse
|
13
|
Yamakawa J, Hashimoto J, Takano M, Takagi M. The Bone Regeneration Using Bone Marrow Stromal Cells with Moderate Concentration Platelet-Rich Plasma in Femoral Segmental Defect of Rats. Open Orthop J 2017; 11:1-11. [PMID: 28217215 PMCID: PMC5301304 DOI: 10.2174/1874325001711010001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/12/2016] [Revised: 12/09/2016] [Accepted: 12/13/2016] [Indexed: 11/22/2022] Open
Abstract
Background: Platelet-rich plasma (PRP) can provide an assortment of growth factors, but how PRP effects bone regeneration is still unknown. The aim of the study was to explore an optimal method of using PRP and bone marrow stromal cells (BMSCs). Methods: An in vitro experiment was first conducted to determine an appropriate quantity of PRP. BMSCs were cultured with PRP of different concentrations to assess cell proliferation and osteogenic differentiation. Following the in vitro study, a rat femoral segmental defect model was used. Five collagen mixtures consisting of different concentrations of PRP and BMSCs were prepared as follows, i) BMSCs and PRP (platelet 20 x 104/µl), ii) BMSCs and PRP (platelet 100 x 104/µl), iii) BMSCs and PRP (platelet 500 x 104/µl), iv) BMSCs, and v) PRP group (platelet 100 x 104/µl), were used to fill defect. New bone formation was evaluated by soft X-ray and histologic analyses were performed at 2, 4, 6 and 8 weeks postoperatively. Results: The cell proliferation increased PRP concentration-dependently. Cellular alkaline phosphatase activity was higher in moderate concentration than high or low concentration group’s in vitro study. In vivo study, the bone fill percentage of newly formed bone in BMSCs and PRP (platelet 100 x 104/µl) was 46.9% at 8 weeks and increased significantly compared with other groups. Conclusion: BMSCs with moderate level of PRP significantly enhanced bone formation in comparison with BMSCs or PRP transplant in a rat femoral defect model.
Collapse
Affiliation(s)
- Junichi Yamakawa
- Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan
| | - Junichi Hashimoto
- Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan
| | - Mitsuo Takano
- Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan
| | - Michiaki Takagi
- Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan
| |
Collapse
|
14
|
Hashimoto J, Abe S, Ishimori Y, Monma M, Tsumuraya A, Miyauchi K. [Proposal of a New Index Based on Signal-to-Noise Ratio for Low-contrast Detectability in Computed Tomographic Imaging]. Nihon Hoshasen Gijutsu Gakkai Zasshi 2017; 73:537-547. [PMID: 28724865 DOI: 10.6009/jjrt.2017_jsrt_73.7.537] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The low-contrast detectability of computed tomography (CT) images is commonly evaluated by the contrast-to-noise ratio (CNR) because of its convenience to measure. However, the correlation between CNR and visual detectability is poor because the CNR is a simple index determined by both the contrast of the object and the standard deviation of the image noise. On the other hand, the signal-to-noise ratio (SNR), especially SNR based on the statistical decision theory model (SNRS, D) and SNR based on the matched-filter model (SNRM) are considered superior to CNR. In this study, we investigated a new physical image quality index for evaluating low-contrast detectability (SNRA), which is approximately derived from SNRS, D and SNRM. The new index, which was calculated using the object size, contrast of the object and the noise power spectrum, provided good approximations when the diameter of the rod object was equal and >5 mm. The diameter dependency of the SNRA was also found to provide better sensitivity than the sensitivities of CNR and object-specific CNR, similar to SNRS, D and SNRM. The results suggested that the proposed convenient index should be useful for evaluating the low-contrast detectability of CT images.
Collapse
Affiliation(s)
- Junichi Hashimoto
- Department of Radiology, Tokyo Medical University Ibaraki Medical Center
- Graduate School of Health Sciences, Ibaraki Prefectural University of Health Sciences
| | - Shinji Abe
- Graduate School of Health Sciences, Ibaraki Prefectural University of Health Sciences
| | - Yoshiyuki Ishimori
- Graduate School of Health Sciences, Ibaraki Prefectural University of Health Sciences
| | - Masahiko Monma
- Graduate School of Health Sciences, Ibaraki Prefectural University of Health Sciences
| | - Akio Tsumuraya
- Department of Radiology, Tokyo Medical University Ibaraki Medical Center
| | - Kaneyoshi Miyauchi
- Department of Radiology, Tokyo Medical University Ibaraki Medical Center
| |
Collapse
|
15
|
Lee S, Suzuki T, Hashimoto J. P-2 Effects of warm-up on muscle activity and deep muscle temperature in different sites. Br J Sports Med 2016. [DOI: 10.1136/bjsports-2016-097120.55] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
16
|
Lee S, Suzuki T, Hashimoto J. P-1 Effect of warm-up by running on successive changes in motor nerve conduction velocity. Br J Sports Med 2016. [DOI: 10.1136/bjsports-2016-097120.54] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
17
|
Kida K, Sumitani M, Ogata T, Kotake R, Natori A, Hashimoto J, Yamauchi H, Yamauchi T. Serum phosphorylated neurofilament heavy subunit as a predictive marker of chemotherapy-induced cognitive impairment: a preliminary result. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw363.84] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Ito Y, Kato K, Hashimoto J, Akimoto T, Katano S, Saito Y, Igaki H. Phase 2 Study of Neoadjuvant Chemoradiation Therapy With Cisplatin Plus 5-Fluorouracil and Elective Nodal Irradiation Followed by Surgery for Stage II/III Esophageal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.1024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
19
|
Kojima T, Ishikawa H, Nishida K, Tanaka S, Haga N, Yukioka M, Miyahara H, Hashimoto J, KImura T, Oda H, Niki Y, Liu M, Kojima M, Ishiguro N. FRI0102 Characteristics of Functional Impairment in Patients with Long-Standing Rheumatoid Arthritis Based on Range of Motion of Joints: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
20
|
Matsushita M, Okada M, Kobayashi T, Yoshie H, Kuzuya K, Matsuoka H, Shimizu T, Nii T, Teshigawara S, Tanaka E, Tsuji S, Ohshima S, Hashimoto J, Saeki Y. AB0282 Predicting The Responses To Biological Therapy by Two Kinds of Antibodies Titers against Porphyromonas Gingivalis in RA Patients. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
21
|
Ebina K, Noguchi T, Hirao M, Hashimoto J, Kaneshiro S, Yukioka M, Yoshikawa H. Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study. Osteoporos Int 2016; 27:351-9. [PMID: 26475289 DOI: 10.1007/s00198-015-3369-6] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Accepted: 10/07/2015] [Indexed: 01/06/2023]
Abstract
UNLABELLED Switching weekly ALN or RIS to monthly MIN in patients with RA, of whom two-thirds were treated with low-dose PSL, significantly decreased bone turnover markers and increased BMD at 12 months, suggesting that monthly MIN may be an effective alternative treatment option of oral bisphosphonate treatment. INTRODUCTION The aim of this prospective, observational study was to evaluate the effects of switching weekly alendronate (ALN 35 mg) or risedronate (RIS 17.5 mg) to monthly minodronate (MIN 50 mg) in patients with rheumatoid arthritis (RA). METHODS Patient characteristics were as follows: n = 172; 155 postmenopausal women, age 65.5 (44–87) years; T-score of lumbar spine (LS), −1.4; total hip (TH), −1.8; femoral neck (FN), −2.1; dose and rate of oral prednisolone (2.3 mg/day), 69.1 %; prior duration of ALN or RIS, 46.6 months; were allocated, based on their preference, to either the (1) continue group (n = 88), (2) switch-from-ALN group (n = 44), or (3) switch-from-RIS group (n = 40). RESULTS After 12 months, increase in BMD was significantly greater in group 3 compared to group 1: LS (4.1 vs 1.2 %; P < 0.001), TH (1.9 vs −0.7 %; P < 0.01), and FN (2.7 vs −0.5 %; P < 0.05); and in group 2 compared to group 1: LS (3.2 vs 1.2 %; P < 0.05) and TH (1.5 vs −0.7 %; P < 0.01). The decrease in bone turnover markers was significantly greater in group 3 compared to group 1: TRACP-5b (−37.3 vs 2.5 %; P < 0.001), PINP (−24.7 vs −6.2 %; P < 0.05), and ucOC (−39.2 vs 13.0 %; P < 0.05); and in group 2 compared to group 1: TRACP-5b (−12.5 vs 2.5 %; P < 0.05) at 12 months. CONCLUSIONS Switching weekly ALN or RIS to monthly MIN in patients with RA may be an effective alternative treatment option of oral bisphosphonate treatment.
Collapse
|
22
|
Abstract
Effective acidic pH-selective liposomal membrane lysis was achieved by using a novel designed peptide.
Collapse
Affiliation(s)
- A. Kashiwada
- Department of Applied Molecular Chemistry
- Graduate School of Industrial Technology
- Nihon University
- Narashino
- Japan
| | - M. Mizuno
- Department of Applied Molecular Chemistry
- Graduate School of Industrial Technology
- Nihon University
- Narashino
- Japan
| | - J. Hashimoto
- Department of Applied Molecular Chemistry
- Graduate School of Industrial Technology
- Nihon University
- Narashino
- Japan
| |
Collapse
|
23
|
Nakamura T, Ito M, Hashimoto J, Shinomiya K, Asao Y, Katsumata K, Hagino H, Inoue T, Nakano T, Mizunuma H. Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis. Osteoporos Int 2015; 26:2685-93. [PMID: 26001561 PMCID: PMC4605968 DOI: 10.1007/s00198-015-3175-1] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2015] [Accepted: 05/13/2015] [Indexed: 11/13/2022]
Abstract
UNLABELLED The MOVEST study evaluated the efficacy and safety of monthly oral ibandronate versus licensed monthly IV ibandronate in Japanese osteoporotic patients. Relative BMD gains after 12 months were 5.22 % oral and 5.34 % IV, showing non-inferiority of oral to IV ibandronate (primary endpoint). No new safety concerns were identified. INTRODUCTION The randomized, phase 3, double-blind MOVEST (Monthly Oral VErsus intravenouS ibandronaTe) study evaluated the efficacy and safety of monthly oral ibandronate versus the licensed monthly intravenous (IV) ibandronate regimen in Japanese patients with osteoporosis. METHODS Ambulatory patients aged ≥ 55 years with primary osteoporosis were randomized to receive oral ibandronate 100 mg/month plus monthly IV placebo, or IV ibandronate 1 mg/month plus monthly oral placebo. The primary endpoint was non-inferiority of oral versus IV ibandronate with respect to bone mineral density (BMD) gains at the lumbar spine after 12 months of treatment. RESULTS Four hundred twenty-two patients were enrolled with 372 patients in the per-protocol set (183 and 189 in the oral and IV ibandronate groups, respectively). The relative change from baseline in lumbar spine BMD values for the oral and IV ibandronate groups, respectively, was 5.22 % (95 % confidence interval [CI] 4.65, 5.80) and 5.34 % (95 % CI 4.78, 5.90). The least squares mean difference between the two groups was -0.23 % (95 % CI -0.97, 0.51), showing non-inferiority of oral ibandronate to IV ibandronate (non-inferiority limit = -1.60). Changes in BMD values at other sites, and bone turnover marker levels in the oral ibandronate group, were comparable with those of the IV group. The safety profile was similar to that previously demonstrated; no new safety concerns were identified. CONCLUSIONS This study demonstrated the non-inferiority of oral ibandronate 100 mg/month to IV ibandronate 1 mg/month (licensed dose in Japan) in increasing lumbar spine BMD in Japanese patients with primary osteoporosis.
Collapse
Affiliation(s)
- T Nakamura
- National Center for Global Health and Medicine, Tokyo, Japan
| | - M Ito
- Center for Gender Equality, Nagasaki University, Nagasaki, Japan
| | - J Hashimoto
- Chugai Pharmaceutical Co. Ltd., Tokyo, Japan.
| | - K Shinomiya
- Chugai Pharmaceutical Co. Ltd., Tokyo, Japan
| | - Y Asao
- Chugai Pharmaceutical Co. Ltd., Tokyo, Japan
| | - K Katsumata
- Chugai Pharmaceutical Co. Ltd., Tokyo, Japan
| | - H Hagino
- School of Health Science & Rehabilitation Division, Tottori University Faculty of Medicine, Tottori, Japan
| | - T Inoue
- Taisho Pharmaceutical Co. Ltd., Tokyo, Japan
| | - T Nakano
- Tamana Central Hospital, Kumamoto, Japan
| | - H Mizunuma
- Department of Obstetrics & Gynecology, Hirosaki University School of Medicine, Hirosaki, Japan
| | | |
Collapse
|
24
|
Hasegawa Y, Takahashi M, Ariki S, Asakawa D, Tajiri M, Wada Y, Yamaguchi Y, Nishitani C, Takamiya R, Saito A, Uehara Y, Hashimoto J, Kurimura Y, Takahashi H, Kuroki Y. Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling. Oncogene 2015; 34:4285-6. [PMID: 26250851 DOI: 10.1038/onc.2015.266] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
25
|
Hashimoto J, Hamasaki Y, Yanagisawa T, Sekine T, Aikawa A, Shishido S. Successful Kidney Transplantation in Epstein Syndrome With Antiplatelet Antibodies and Donor-specific Antibodies: A Case Report. Transplant Proc 2015; 47:2541-3. [DOI: 10.1016/j.transproceed.2015.09.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2015] [Accepted: 09/02/2015] [Indexed: 11/30/2022]
|
26
|
Tsuji S, Higashiyama M, Tomita T, Matsui M, Tsuboi H, Hashimoto J. SAT0581 Predictors of Minimal Disease Activity in Patients Treated with Adalimumab for 52 Weeks in Clinical Practice. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
27
|
Tsuji S, Higashiyama M, Tomita T, Matsui M, Tsuboi H, Hashimoto J. THU0434 Bone Density and Metabolism with Disease Condition in Psoriatic Arthritis After Treatment with Adalimumab for 52 Weeks. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
28
|
Kojima T, Ishikawa H, Nishida K, Hashimoto J, Miyahara H, Tanaka S, Haga N, Niki Y, Kojima M, Ishiguro N. THU0602 Relationship Between Index of Activity Speed (Time Up and Go Test) and Patient-Reported Outcome in Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
29
|
Ebina K, Hashimoto J, Hirao M, Hagihara K, Noguchi T, Yoshikawa H. FRI0301 Assessment of the Effect of 12 Months Administration of Denosumab in Patients with Rheumatic Diseases – Bone Mineral Density Increase in Lumbar Spine is Negatively Correlated with Baseline Oral Prednisolone Dose and Predicted by Decreasing Rate of Serum Undercarboxylated Osteocalcin at 6 Months. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
30
|
Lee S, Suzuki T, Hashimoto J, Fujita C, Kannari K. Increased bone strength through strong mechanical stress suppresses the growth of long bone axes. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.1674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
31
|
Ebina K, Hashimoto J, Shi K, Kashii M, Hirao M, Yoshikawa H. Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda. Osteoporos Int 2015; 26:1445. [PMID: 25524021 DOI: 10.1007/s00198-014-2993-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/18/2014] [Accepted: 12/08/2014] [Indexed: 01/28/2023]
Affiliation(s)
- K Ebina
- Department of Orthopaedic Surgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, 565-0871, Osaka, Japan,
| | | | | | | | | | | |
Collapse
|
32
|
Kikuchi-Taura A, Yura A, Tsuji S, Ohshima S, Kitatoube A, Shimizu T, Nii T, Katayama M, Teshigawara S, Yoshimura M, Kudo-Tanaka E, Harada Y, Matsushita M, Hashimoto J, Saeki Y. Monocyte CD64 expression as a novel biomarker for the disease activity of systemic lupus erythematosus. Lupus 2015; 24:1076-80. [DOI: 10.1177/0961203315579093] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2014] [Accepted: 03/02/2015] [Indexed: 12/19/2022]
Abstract
Objective Interferon alpha (IFN-α) is a key cytokine associated with systemic lupus erythematosus (SLE). IFN-α induces the expression of CD64 on monocytes (mCD64). Although enhanced mCD64 expression has been reported in patients with SLE, it has never been assessed quantitatively. The aim of this study was to investigate whether or not mCD64 expression correlates with SLE disease activity. Methods The mCD64 expression levels were assessed quantitatively in 40 patients with active or inactive SLE by using flow cytometry. The mCD64 expression levels were subsequently compared with the SLE disease activity index (SLEDAI) and levels of existing SLE activity biomarkers, such as anti-DNA antibody, complements, and so on. Results The mCD64 expression was significantly higher in active disease than in inactive disease SLE (median molecules/cell, interquartile range: 34,648, 8174–24,932 and 20,865, 6357–21,503, respectively; p < 0.001). The levels of mCD64 expression strongly correlated with SLEDAI ( r = 0.68, p < 0.001). Conclusion The mCD64 expression is a simple and useful biomarker for evaluating disease activity in patients with SLE.
Collapse
Affiliation(s)
- A Kikuchi-Taura
- Department of Clinical Research, Osaka-Minami Medical Center, Osaka, Japan
| | - A Yura
- Department of Rheumatology and Allergology, Osaka-Minami Medical Center, Osaka, Japan
| | - S Tsuji
- Department of Rheumatology and Allergology, Osaka-Minami Medical Center, Osaka, Japan
| | - S Ohshima
- Department of Clinical Research, Osaka-Minami Medical Center, Osaka, Japan
| | - A Kitatoube
- Department of Clinical Research, Osaka-Minami Medical Center, Osaka, Japan
| | - T Shimizu
- Department of Rheumatology and Allergology, Osaka-Minami Medical Center, Osaka, Japan
| | - T Nii
- Department of Rheumatology and Allergology, Osaka-Minami Medical Center, Osaka, Japan
| | - M Katayama
- Department of Rheumatology and Allergology, Osaka University, Graduate School of Medicine, Osaka, Japan
| | - S Teshigawara
- Department of Rheumatology and Allergology, Osaka-Minami Medical Center, Osaka, Japan
| | - M Yoshimura
- Department of Rheumatology and Allergology, Osaka-Minami Medical Center, Osaka, Japan
| | - E Kudo-Tanaka
- Department of Rheumatology and Allergology, Osaka-Minami Medical Center, Osaka, Japan
| | - Y Harada
- Department of Rheumatology and Allergology, Osaka-Minami Medical Center, Osaka, Japan
| | - M Matsushita
- Department of Rheumatology and Allergology, Osaka-Minami Medical Center, Osaka, Japan
| | - J Hashimoto
- Department of Rheumatology and Allergology, Osaka-Minami Medical Center, Osaka, Japan
| | - Y Saeki
- Department of Clinical Research, Osaka-Minami Medical Center, Osaka, Japan
| |
Collapse
|
33
|
Ebina K, Hashimoto J, Shi K, Kashii M, Hirao M, Yoshikawa H. Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients. Osteoporos Int 2014; 25:2755-65. [PMID: 25082556 DOI: 10.1007/s00198-014-2819-x] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2014] [Accepted: 07/22/2014] [Indexed: 01/09/2023]
Abstract
UNLABELLED Patients with rheumatoid arthritis showed greater response to 18-month administration of daily teriparatide especially in the increase of bone formation markers at 1 month and femoral neck bone mineral density at 18 months compared to postmenopausal osteoporosis patients. INTRODUCTION The aim of this study was to evaluate the effects of 18-month administration of daily teriparatide (TPTD) in osteoporosis patients with rheumatoid arthritis (RA) by comparing that of postmenopausal osteoporosis patients (Porosis). METHODS The effects of TPTD were examined between RA (n = 70; age 68.4 years; disease activity score assessing 28 joints with CRP [DAS28-CRP] 2.8; rheumatoid factor [RF] positivity 75.5 %) with 77.1 % of prior bisphosphonate (BP), 84.3 % of oral prednisolone (PSL) (4.4 mg/day at baseline), 25.7 % of biologics, and Porosis (n = 62; age 71.3 years) with 77.4 % of prior BP. RESULTS Femoral neck (FN) bone mineral density (BMD) increase at 18 months was significantly greater in RA compared to Porosis (4.7 vs. 0.7 %, P = 0.038), whereas it was 9.7 versus 7.9 % (P = 0.736) in the lumbar spine (LS). The increase of bone formation markers (bone alkaline phosphatase [bone ALP] and N-terminal type I procollagen propeptide [PINP]) at 1 month were all significantly greater in RA compared to Porosis. A multivariate logistic regression analysis revealed that the significant indicator of 18-month BMD increase in RA was a 3-month increase of under-carboxylated osteocalcin (ucOC) for LS (β = 0.446, P = 0.005) and baseline ucOC for FN (β = 0.554, P = 0.001), in which both showed significant negative correlation with baseline PSL dose. CONCLUSIONS RA showed greater response to daily TPTD administration, especially in the increase of bone formation markers at 1 month and FN BMD increase at 18 months compared to Porosis.
Collapse
Affiliation(s)
- K Ebina
- Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan,
| | | | | | | | | | | |
Collapse
|
34
|
Brandt TD, McElwain MW, Turner EL, Mede K, Spiegel DS, Kuzuhara M, Schlieder JE, Wisniewski JP, Abe L, Biller B, Brandner W, Carson J, Currie T, Egner S, Feldt M, Golota T, Goto M, Grady CA, Guyon O, Hashimoto J, Hayano Y, Hayashi M, Hayashi S, Henning T, Hodapp KW, Inutsuka S, Ishii M, Iye M, Janson M, Kandori R, Knapp GR, Kudo T, Kusakabe N, Kwon J, Matsuo T, Miyama S, Morino JI, Moro-Martín A, Nishimura T, Pyo TS, Serabyn E, Suto H, Suzuki R, Takami M, Takato N, Terada H, Thalmann C, Tomono D, Watanabe M, Yamada T, Takami H, Usuda T, Tamura M. A STATISTICAL ANALYSIS OF SEEDS AND OTHER HIGH-CONTRAST EXOPLANET SURVEYS: MASSIVE PLANETS OR LOW-MASS BROWN DWARFS? ACTA ACUST UNITED AC 2014. [DOI: 10.1088/0004-637x/794/2/159] [Citation(s) in RCA: 118] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
35
|
Tanaka R, Yonemori K, Hirakawa A, Hashimoto J, Kodaira M, Yamamoto H, Yunokawa M, Shimizu C, Fujimoto M, Fujiwara Y, Tamura K. Risk Factors for Developing Skeletal-Related Events Associated with Metastatic Breast Cancer Patients Receiving Bone-Modifying Agents. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu329.28] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
36
|
Ito Y, Kato K, Hashimoto J, Akimoto T, Katano S, Saito Y, Igaki H. Phase 2 Study of Neoadjuvant Chemoradiation Therapy With Cisplatin Plus 5-Fluorouracil and Elective Nodal Irradiation for Stage II/III Esophageal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.1109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
37
|
Esaki T, Seto T, Hirai F, Arita S, Toyokawa G, Hashimoto J, Tanabe Y, Kodaira M, Yonemori K, Hoshino Y, Yamamoto H, Kawata T, Lindemann J, Tamura K. A Phase I Study to Assess the Safety and Tolerability of the Selective Akt Inhibitor Azd5363 in Japanese Patients with Advanced Solid Tumours. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu331.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Bun S, Yunokawa M, Kodaira M, Hashimoto J, Yamamoto H, Shimizu C, Fujiwara Y, Makino Y, Iwase H, Tamura K, Hayashi Y. Feasibility of Dose-Dense Paclitaxel/Carboplatin Therapy in Elderly Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu338.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Okuma H, Koizumi F, Hirakawa A, Nakatochi M, Hashimoto J, Kodaira M, Yunokawa M, Yamamoto H, Yonemori K, Shimizu C, Fujiwara Y, Tamura K. Integrative Analysis of Two Prospective Neoadjuvant Studies with Breast Cancer Patients and Microarray Analysis. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu358.6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
40
|
Shimoi T, Hamada A, Yonemori K, Shimma S, Osawa S, Tanabe Y, Hashimoto J, Kodaira M, Yunokawa M, Yamamoto H, Shimizu C, Fujiwara Y, Tamura K. Imaging Mass Spectrometry of Novel Drug in Human Tumor Specimens: Distribution of Unlabeled Drugs to Support Early Phase Clinical Trial. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu331.1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
41
|
Yoshikane Y, Koga M, Imanaka-Yoshida K, Cho T, Yamamoto Y, Yoshida T, Hashimoto J, Hirose S, Yoshimura K. JNK is critical for the development of Candida albicans-induced vascular lesions in a mouse model of Kawasaki disease. Cardiovasc Pathol 2014; 24:33-40. [PMID: 25242023 DOI: 10.1016/j.carpath.2014.08.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2014] [Revised: 07/29/2014] [Accepted: 08/21/2014] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND Kawasaki disease (KD) is the most common systemic vasculitis of unknown etiology in children, and can cause the life-threatening complication of coronary artery aneurysm. Although a novel treatment strategy for patients with KD-caused vascular lesions is eagerly awaited, their molecular pathogenesis remains largely unknown. c-Jun N-terminal kinase (JNK) is a signaling molecule known to have roles in inflammation and tissue remodeling. The aim of this study was to elucidate significant involvement of JNK in the development of vascular lesions in a mouse model of KD. METHODS AND RESULTS We injected Candida albicans cell wall extract (CAWE) into 4-week-old C57BL/6 mice. Macroscopically, we found that CAWE caused the development of bulging lesions at coronary artery, carotid artery, celiac artery, iliac artery and abdominal aorta. Histological examination of coronary artery and abdominal aorta in CAWE-treated mice showed marked inflammatory cell infiltration, destruction of elastic lamellae, loss of medial smooth muscle cells and intimal thickening, which are similar to histological features of vascular lesions of patients with KD. To find the role of JNK in lesion formation, we evaluated the effects of JNK inhibitor, SP600125, on abdominal aortic lesions induced by CAWE. Interestingly, treatment with SP600125 significantly decreased the incidence of lesions and also protected against vascular inflammation and tissue destruction histologically, compared with the placebo treatment. CONCLUSIONS Our findings suggest that JNK is crucial for the development of CAWE-induced vascular lesions in mice, and potentially represents a novel therapeutic target for KD.
Collapse
Affiliation(s)
- Yukako Yoshikane
- Department of Pediatrics, Faculty of Medicine, Fukuoka University, Fukuoka, 814-0180, Japan.
| | - Mitsuhisa Koga
- Department of Pharmaceutical Care and Health Sciences, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, 814-0180, Japan
| | - Kyoko Imanaka-Yoshida
- Department of Pathology and Matrix Biology, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan; Mie University Research Center for Matrix Biology, Mie University, Tsu, 514-8507, Japan
| | - Tamaki Cho
- Section of Infection Biology, Department of Functional Bioscience, Fukuoka Dental College, Fukuoka, 814-0193, Japan
| | - Yumi Yamamoto
- Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, 755-8505, Japan
| | - Toshimichi Yoshida
- Department of Pathology and Matrix Biology, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan; Mie University Research Center for Matrix Biology, Mie University, Tsu, 514-8507, Japan
| | - Junichi Hashimoto
- Department of Pediatrics, Faculty of Medicine, Fukuoka University, Fukuoka, 814-0180, Japan
| | - Shinichi Hirose
- Department of Pediatrics, Faculty of Medicine, Fukuoka University, Fukuoka, 814-0180, Japan
| | - Koichi Yoshimura
- Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, 755-8505, Japan; Graduate School of Health and Welfare, Yamaguchi Prefectural University, Yamaguchi, 753-8502, Japan
| |
Collapse
|
42
|
Tsuji S, Yura A, Katayama M, Watanabe A, Teshigawara S, Yoshimura M, Tanaka E, Harada Y, Kagawa K, Katada Y, Matsushita M, Ohshima S, Hashimoto J, Saeki Y. AB0449 Baseline Procalcitonin (PCT) Level as A Predictive Marker for Clinical Remission (DAS28-ESR, CDAI) at 52 Weeks in Biologic NaÏVe Rheumatoid Arthritis (RA) Patients Treated by TOCILIZUMAB (TCZ); A Single Center Retrospective Study. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2437] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
43
|
Kikuchi-Taura A, Tsuji S, Ohshima S, Yura A, Katayama M, Watanabe A, Teshigawara S, Yoshimura M, Kudo-Tanaka E, Harada Y, Katada Y, Matsushita M, Kitatoube A, Hashimoto J, Saeki Y. AB0943 Monocyte/Neutrophil (M/N) CD64 Ratio is Useful for Differentiating Infection from Disease Activity in Systemic Lupus Erythematosus (SLE) Patients: Table 1. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
44
|
Kikuchi-Taura A, Tsuji S, Ohshima S, Yura A, Katayama M, Watanabe A, Teshigawara S, Yoshimura M, Kudo-Tanaka E, Harada Y, Katada Y, Matsushita M, Kitatoube A, Hashimoto J, Saeki Y. SAT0002 Quantitative CD64 Molecules on Peripheral Blood Monocytes in Systemic Lupus Erythematosus (SLE). Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
45
|
Kojima T, Ishikawa H, Nishida K, Hashimoto J, Miyahara H, Tanaka S, Haga N, Niki Y, Kojima M, Ishiguro N. AB1113 Characteristics of Physical Disability in Patients with Long-Standing Rheumatoid Arthritis: Baseline Analysis of Multicenter Prospective Cohort Study for Evaluation of Joint Reconstructive Procedure. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1789] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
46
|
Tanaka E, Katayama M, Satoru T, Yoshimura M, Watanabe A, Tsuji S, Tsuboi H, Hirao M, Yura A, Harada Y, Katada Y, Matsushita M, Hashimoto J, Oshima S, Saeki Y. THU0249 Early Therapeutic Intervention with Methotrexate (MTX) Prevents Development of Rheumatoid Arthritis (RA) in Patients with Undifferentiated Arthritis (UA), Even in the Presence of Smoking or the HLA-DR B1-Shared Epitope. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
47
|
Teshigawara S, Tsuji S, Kikuchi-Taura A, Yura A, Katayama M, Watanabe A, Yoshimura M, Kudo-Tanaka E, Harada Y, Katada Y, Matsushita M, Ohshima S, Hashimoto J, Saeki Y. FRI0091 Neutrophil CD64 (NCD64) as A Useful Marker for Differentiating Organizing Pneumonia (OP) from Bacterial Pneumonia (BP) in Rheumatoid Arthritis (RA):. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
48
|
Katada Y, Harada Y, Yura A, Yoshimura M, Katayama M, Teshigawara S, Tanaka E, Watanabe A, Oshima S, Tsuji S, Saeki Y, Murata J, Nakanishi F, Masuda E, Hijioka T, Yamaguchi N, Hashimoto J, Matsushita M. AB0940 The Prevalence of Achalasia among Patients with Autoimmune Diseases. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.4910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
49
|
Katayama M, Tsuji S, Kikuchi-Taura A, Kitatobe A, Yura A, Teshigawara S, Yoshimura M, Watanabe A, Kudo-Tanaka E, Harada Y, Matsushita M, Katada Y, Oshima S, Hashimoto J, Saeki Y. FRI0079 Plasma Pentraxin3 (PTX3) as A Novel Useful Biomarker for Infection in Patients with Rheumatoid Arthritis (RA). Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
50
|
Yura A, Tsuji S, Kitatoube A, Kikuchi-Taura A, Katayama M, Watanabe A, Teshigawara S, Yoshimura M, Kudo-Tanaka E, Harada Y, Matsushita M, Katada Y, Ohshima S, Hashimoto J, Saeki Y. SAT0003 Quantitative Monocyte CD64 (MCD64) Expression is Useful Biomarker for Disease Activity in Systemic Lupus Erythematosus (SLE) Patients: Table 1. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|